Incidental Radiologic Findings in the 22q11.2 Deletion Syndrome

References

1. 1.↵
   2. Shprintzen RJ

   . Velo-cardio-facial syndrome: 30 years of study. Dev Disabil Res Rev 2008;14:3–10

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Driscoll D,
   3. Salvin J,
   4. Sellinger B, et al

   . Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. J Med Genet 1993;30:813–17

   Abstract/FREE Full Text
3. 3.↵
   2. Edelmann L,
   3. Pandita RK,
   4. Morrow BE

   . Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome. Am J Hum Genet 1999;64:1076–86

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Shaikh TH,
   3. Kurahashi H,
   4. Saitta SC, et al

   . Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum Mol Genet 2000;9:489–501

   Abstract/FREE Full Text
5. 5.↵
   2. Eisenberg DP,
   3. Jabbi M,
   4. Berman KF

   . Bridging the gene-behavior divide through neuroimaging deletion syndromes: velocardiofacial (22q11.2 deletion) and Williams (7q11.23 deletion) syndromes. Neuroimage 2010;53:857–69

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Gothelf D,
   3. Furfaro JA,
   4. Penniman LC, et al

   . The contribution of novel brain imaging techniques to understanding the neurobiology of mental retardation and developmental disabilities. Ment Retard Dev Disabil Res Rev 2005;11:331–39

   CrossRefPubMed
7. 7.↵
   2. Gothelf D,
   3. Lombroso PJ

   . Genetics of childhood disorders. XXV. Velocardiofacial syndrome. J Am Acad Child Adolesc Psychiatry 2001;40:489–91

   CrossRefPubMed
8. 8.↵
   2. Baker KD,
   3. Skuse DH

   . Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group. Br J Psychiatry 2005;18:115–20
9. 9.↵
   2. Murphy KC,
   3. Jones LA,
   4. Owen MJ

   . High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999;56:940–45

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Bassett A,
    3. Chow E

    . 22Q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry 1999;46:882–91

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Gothelf D,
    3. Schaer M,
    4. Eliez S

    . Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome. Dev Disabil Res Rev 2008;14:59–68

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Schaer M,
    3. Schmitt JE,
    4. Glaser B, et al

    . Abnormal patterns of cortical gyrification in velo-cardio-facial syndrome (deletion 22q11.2): an MRI study. Psychiatry Res 2006;146:1–11

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Eliez S,
    3. Schmitt JE,
    4. White CD, et al

    . Children and adolescents with velocardiofacial syndrome: a volumetric MRI study. Am J Psychiatry 2000;157:409–15

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Bearden CE,
    3. van Erp TG,
    4. Dutton RA, et al

    . Mapping cortical thickness in children with 22q11.2 deletions. Cerebral Cortex 2007:17:1889–98

    Abstract/FREE Full Text
15. 15.↵
    2. van Amelsvoort T,
    3. Daly E,
    4. Robertson D, et al

    . Structural brain abnormalities associated with deletion at chromosome 22q11: quantitative neuroimaging study of adults with velo-cardio-facial syndrome. Br J Psychiatry 2001;178:412–19

    Abstract/FREE Full Text
16. 16.↵
    2. Eliez S,
    3. Schmitt JE,
    4. White CD, et al

    . A quantitative MRI study of posterior fossa development in velocardiofacial syndrome. Biol Psychiatry 2001;49:540–46

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Chow EW,
    3. Mikulis DJ,
    4. Zipursky RB, et al

    . Qualitative MRI findings in adults with 22q11 deletion syndrome and schizophrenia. Biol Psychiatry 1999;46:1436–42

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Beaton EA,
    3. Qin Y,
    4. Nguyen V, et al

    . Increased incidence and size of cavum septum pellucidum in children with chromosome 22q11.2 deletion syndrome. Psychiatry Res 2010;181:108–13

    CrossRefPubMed
19. 19.↵
    2. Galarza M,
    3. Merlo AB,
    4. Ingratta A, et al

    . Cavum septum pellucidum and its increased prevalence in schizophrenia: a neuroembryological classification. J Neuropsychiatry Clin Neurosci 2004;16:41–46

    CrossRefPubMed
20. 20.↵
    2. Trzesniak C,
    3. Oliveira IR,
    4. Kempton MJ, et al

    . Are cavum septum pellucidum abnormalities more common in schizophrenia spectrum disorders? A systematic review and meta-analysis. Schizophr Res 2011;125:1–12

    CrossRefPubMed
21. 21.↵
    2. Seki A,
    3. Uchiyama H,
    4. Fukushi T, et al

    . Incidental findings of brain magnetic resonance imaging study in a pediatric cohort in Japan and recommendation for a model management protocol. J Epidemiol 2010:20(supplement 2):S498–504

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Morris Z,
    3. Whiteley W,
    4. Longstreth WT Jr., et al

    . Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2009;33:b3016
23. 23.↵
    2. Vernooij MW,
    3. Ikram MA,
    4. Tanghe HL, et al

    . Incidental findings on brain MRI in the general population. N Engl J Med 2007;357:1821–28

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Katzman GL,
    3. Dagher AP,
    4. Patronas NJ

    . Incidental findings on brain from 1000 asymptomatic volunteers. JAMA 1999;282:36–39

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Gur R,
    3. Kaltman D,
    4. Melhem E, et al

    . Incidental findings in youths volunteering for brain MRI research. AJNR Am J Neuroradiol 2013;34:2021–25

    Abstract/FREE Full Text
26. 26.↵
    2. Wilkinson G,
    3. Robertson G

    . Wide Range Achievement Test. 4th ed. Lutz: Psychological Assessment Resources; 2006
27. 27.↵
    2. Tang SX,
    3. Yi JJ,
    4. Calkins ME, et al

    . Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated. Psychol Med 2013:1–11
28. 28.↵
    2. Jalali GR,
    3. Vorstman JA,
    4. Errami A, et al

    . Detailed analysis of 22q11.2 with a high density MLPA probe set. Human Mutat 2008;29:433–40

    CrossRefPubMed
29. 29.↵
    R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2014. http://www.R-project.org. Accessed January 24, 2014.
30. 30.↵
    2. Lemeshow S,
    3. Hosmer D

    . A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 1982;115:92–106

    Abstract/FREE Full Text
31. 31.↵
    2. Akaike H

    . Factor analysis and AIC. Psychometrika 1987;52:317–32

    CrossRefWeb of Science
32. 32.↵
    2. Satterthwaite TD,
    3. Elliott MA,
    4. Ruparel K, et al

    . Neuroimaging of the Philadelphia neurodevelopmental cohort. Neuroimage 2014;86:544–53

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Sylvius F

    . Opera Medica, Tam Hactenus Inedita, Quam Variis Locis et Formis Edita. Amsterdam: Aput Danielem Elsevirium et Abrahamum Wolfgang; 1679
34. 34.↵
    2. Winter TC,
    3. Kennedy AM,
    4. Byrne J, et al

    . The cavum septi pellucidi: why is it important? J Ultrasound Med 2010;29:427–44

    Abstract/FREE Full Text
35. 35.↵
    2. Saba L,
    3. Anzidei M,
    4. Raz E, et al

    . MR and CT of brain's cava. J Neuroimaging 2013;23:326–35

    CrossRefPubMed
36. 36.↵
    2. Aldur MM,
    3. Gürcan F,
    4. Başar R, et al

    . Frequency of septum pellucidum anomalies in non-psychotic population: a magnetic resonance imaging study. Surg Radiol Anat 1999;21:119–23

    CrossRefPubMed
37. 37.↵
    2. Born CM,
    3. Meisenzahl EM,
    4. Frodl T, et al

    . The septum pellucidum and its variants: an MRI study. Eur Arch Psychiatry Clin Neurosci 2004;254:295–302

    PubMed
38. 38.↵
    2. Shashi V,
    3. Muddasani S,
    4. Santos CC, et al

    . Abnormalities of the corpus callosum in nonpsychotic children with chromosome 22q11 deletion syndrome. Neuroimage 2004;21:1399–406

    CrossRefPubMedWeb of Science
39. 39.↵
    2. Bodensteiner JB,
    3. Schaefer GB

    . Wide cavum septum pellucidum: a marker of disturbed brain development. Pediatr Neurol 1990;6:391–94

    CrossRefPubMedWeb of Science
40. 40.↵
    2. May FS,
    3. Chen QC,
    4. Gilbertson MW, et al

    . Cavum septum pellucidum in monozygotic twins discordant for combat exposure: relationship to posttraumatic stress disorder. Biol Psychiatry 2004;55:656–58

    CrossRefPubMed
41. 41.↵
    2. Schaefer GB,
    3. Bodensteiner JB,
    4. Buehler B a, et al

    . The neuroimaging findings in Sotos syndrome. Am J Med Genet 1997:68:462–65

    CrossRefPubMedWeb of Science
42. 42.↵
    2. Johnson VP,
    3. Swayze VW II.,
    4. Sato Y, et al

    . Fetal alcohol syndrome: craniofacial and central nervous system manifestations. Am J Med Genet 1996;61:329–39

    CrossRefPubMedWeb of Science
43. 43.↵
    2. Campbell LE,
    3. Daly E,
    4. Toal F, et al

    . Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel-based morphometry MRI study. Brain 2006:129(pt 5):1218–28

    Abstract/FREE Full Text
44. 44.↵
    2. MacKenzie-Stepner K,
    3. Witzel M,
    4. Stringer D, et al

    . Abnormal carotid arteries in the velocardiofacial syndrome: a report of three cases. Plas Reconstr Surg 1987;80:347–51

    CrossRef
45. 45.↵
    2. Mitnick R,
    3. Bello J,
    4. Golding-Kushner KJ, et al

    . The use of magnetic resonance angiography prior to pharyngeal flap surgery in patients with velocardiofacial syndrome. Plas Reconstr Surg 1996;97:908–19

    CrossRef
46. 46.↵
    2. Shprintzen RJ

    . Velo-cardio-facial syndrome: a distinctive behavioral phenotype. Ment Retard Dev Disabil Res Rev 2000;6:142–47

    CrossRefPubMedWeb of Science
47. 47.↵
    2. Tan GM,
    3. Arnone D,
    4. McIntosh AM, et al

    . Meta-analysis of magnetic resonance imaging studies in chromosome 22q11.2 deletion syndrome (velocardiofacial syndrome). Schizophr Res 2009:115:173–81

    CrossRefPubMed
48. 48.↵
    2. Altman DH,
    3. Altman NR,
    4. Mitnick RJ, et al

    . Further delineation of brain anomalies in velo-cardio-facial syndrome. Am J Med Genet 1995;60:174–75

    CrossRefPubMed
49. 49.↵
    2. Kates WR,
    3. Burnette CP,
    4. Jabs EW, et al

    . Regional cortical white matter reductions in velocardiofacial syndrome: a volumetric MRI analysis. Biol Psychiatry 2001;49:677–84

    CrossRefPubMedWeb of Science
50. 50.↵
    2. Fazekas F,
    3. Kleinert R,
    4. Offenbacher H, et al

    . Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993;43:1683–89

    CrossRef
51. 51.↵
    2. Dupont RM,
    3. Butters N,
    4. Schafer K, et al

    . Diagnostic specificity of focal white matter abnormalities in bipolar and unipolar mood disorder. Bio Psychiatry 1995;38:482–86

    CrossRef
52. 52.↵
    2. Debette S,
    3. Markus H

    . The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010:341
53. 53.↵
    2. Mitnick RJ,
    3. Bello JA,
    4. Shprintzen RJ

    . Brain anomalies in velo-cardio-facial syndrome. Am J Med Genet 1994;54:100–06

    CrossRefPubMedWeb of Science